NFlection Therapeutics
PrivateLast Round
Debt
Jul 20, 2023
Total Funding Raised
$44M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
NFlection Therapeutics is a biopharmaceutical company focused on the discovery and development of targeted topical therapies for rare dermatological disorders driven by aberrant RAS pathway activation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NFlection Therapeutics Comparables
Compare NFlection Therapeutics with similar companies based on industry and business-model similarity.
NFlection Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jul 20, 2023 | ||||
| Series B | Jun 21, 2022 | ||||
| Series A | Jun 9, 2020 |
NFlection Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| F-Prime Capital | Series A |
| venBio | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 19, 2026
Monthly visitors grew 60% MoM.
- Jun 21, 2022
$20M round led by Children's Tumor Foundation.
NFlection Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NFlection Therapeutics's valuation, stock price, and market status.